September 22, 2014 12:31 AM ET

Biotechnology

Company Overview of Oscient Pharmaceuticals Corp.

Company Overview

As of June 30, 2010, Oscient Pharmaceuticals Corp. went out of business. Oscient Pharmaceuticals Corporation, a commercial-stage pharmaceutical company, sells and markets products to primary care physicians, cardiologists, endocrinologists, and pulmonologists in the United States. It markets ANTARA (fenofibrate) capsules, a cardiovascular product for the adjunct treatment of hypercholesterolemia (high blood cholesterol) and hypertriglyceridemia (high triglycerides) in combination with diet; and FACTIVE (gemifloxacin mesylate) tablets, a fluoroquinolone antibiotic for the treatment of acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia of mild to moderate seve...

1000 Winter Street

Suite 2200

Waltham, MA 02451

United States

Founded in 1961

316 Employees

Phone:

781-398-2300

Fax:

781-893-9535

Key Executives for Oscient Pharmaceuticals Corp.

Oscient Pharmaceuticals Corp. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Theron Pharmaceuticals, Inc. United States
MiPod Nuclear Inc. United States
Tendyne Medical, Inc. United States
Optherion, Inc. United States
Martek Biosciences Boulder Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oscient Pharmaceuticals Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.